NC3Rs e-newsletter - April 2015


David Sainsbury Fellowships Scheme

Our David Sainsbury Fellowships support talented, 3Rs-minded, early-career scientists with the transition to an independent career. Applications are accepted from any area of medical, biological or veterinary research. The competition offers fellows an award of £65k per annum for three years. The deadline for submission of informal outlines to the NC3Rs office is 4pm, 15 May 2015.


NC3Rs/Society of Biology joint symposium

10 June 2015 – LONDON
The joint symposium organised by the NC3Rs and the Society of Biology's Animal Sciences Group is a chance to discover the latest scientific and technological advances in the 3Rs.

This year we have allocated four 15 minute slots for early career researchers to present, and there is also an opportunity to present posters on 3Rs relevant research.

This event has been approved for the purposes of CPD by the Society of Biology, and can count as 24 CPD points.

Poster/presentation submission deadline: 18 May
Registration deadline: 25 May


Solutions: Partners sought to validate a novel test for botulinum neurotoxin to replace the mouse bioassay

Researchers from University of Freiburg, Germany, are seeking partners to validate and commercialize their novel automated bioluminescence assay (BLB-Test) for detecting botulinum neurotoxin (BoNT) to replace the mouse bioassay.



From bench to clinic; the impact of an NC3Rs funded project

An NC3Rs funded project has helped pave the way towards a potential treatment for multiple sclerosis (MS). Our Science Manager Katie Lidster reviews the impacts the grant has had since being awarded in 2010.



Efforts to improve the design of animal experiments gathers momentum

Last week saw the publication of updated guidance on funding applications involving the use of animals, by the UK's Research Councils. The announcement was picked up by the specialist and general press, with Nature and the Observer both covering the publication. Our Chief Executive Vicky Robinson discusses how the NC3Rs has been driving improvements in experimental design, analysis, and reporting.


The 3Rs in drug development and safety assessment studies with non-human primates

A new Elsevier book on the use of non-human primates in pharmaceutical drug development contains a chapter specifically focused on opportunities to apply the 3Rs. Led and co-authored by NC3Rs staff with leading experts in the field, it includes guidance on efficient study designs to reduce animal use, and refinement of housing and scientific procedures.